You have 9 free searches left this month | for more free features.

vincristine

Showing 1 - 25 of 268

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial (Biospecimen Collection, Vincristine)

Not yet recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Biospecimen Collection
  • Vincristine
  • (no location specified)
Apr 28, 2022

Sarcoma, Ewing, Rhabdomyosarcoma Trial run by the National Cancer Institute (NCI) (PEN-866, Vincristine, Temozolomide)

Not yet recruiting
  • Sarcoma, Ewing
  • Rhabdomyosarcoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Optic Glioma, Pediatric Brain Tumor, Optic Nerve Glioma Trial in Beijing (Carboplatin, Vincristine, Recombinant human

Not yet recruiting
  • Optic Glioma
  • Pediatric Brain Tumor, Optic Nerve Glioma
  • Beijing, China
    Capital Medical University Sanbo Brain Hospital
Mar 3, 2022

DLBCL Trial in Cleveland (Loncastuximab tesirine, Prednisone, Rituximab)

Withdrawn
  • Diffuse Large B-Cell Lymphoma
  • Loncastuximab tesirine
  • +5 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center
Mar 15, 2022

Diffuse Large B Cell Lymphoma Trial (Rituximab, Cyclophosphamide, Doxorubicin)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • (no location specified)
Apr 24, 2022

Neuroblastoma, Pediatric Cancer Trial in New York (Cyclophosphamide, Topotecan, Vincristine)

Recruiting
  • Neuroblastoma
  • Pediatric Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 11, 2022

Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage Trial in Houston (Clofarabine,

Recruiting
  • Acute Bilineal Leukemia
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Lymphoma Trial in Worldwide (Glofitamab, Tocilizumab, Doxorubicin)

Recruiting
  • Lymphoma
  • Duarte, California
  • +13 more
Aug 18, 2022

Kaposiform Hemangioendothelioma (KHE), Kasabach-Merritt Syndrome, Tufted Angioma Trial in United States (Vincristine, Sirolimus)

Terminated
  • Kaposiform Hemangioendothelioma (KHE)
  • +2 more
  • Palo Alto, California
  • +6 more
May 20, 2021

Solid Tumor Trial in Dallas (Atezolizumab, Vincristine, Irinotecan)

Not yet recruiting
  • Solid Tumor
  • Dallas, Texas
    The University of Texas Southwestern Medical Center
Mar 29, 2022

Diffuse Large B Cell Lymphoma Trial in Zhengzhou (Rituximab, Lenalidomide, Cyclophosphamide)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Aug 15, 2021

Pleuropulmonary Blastoma Trial in Minneapolis (Vincristine, Dactinomycin, Cyclophosphamide)

Active, not recruiting
  • Pleuropulmonary Blastoma
  • Vincristine
  • +4 more
  • Minneapolis, Minnesota
    Anne K Harris
May 26, 2021

Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Memphis (drug, biological, radiation)

Not yet recruiting
  • Refractory Acute Lymphoblastic Leukemia
  • Relapsed Acute Lymphoblastic Leukemia
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 23, 2022

High-risk Large B-cell Lymphoma (LBCL) Trial (Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine)

Not yet recruiting
  • High-risk Large B-cell Lymphoma (LBCL)
  • Axicabtagene Ciloleucel
  • +7 more
  • (no location specified)
Dec 13, 2022

MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)

Not yet recruiting
  • Myelodysplastic Syndromes, de Novo
  • +10 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jul 25, 2022

Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Nanjing, Nanjin (Zanubrutinib, Lenalidomide, Rituximab)

Recruiting
  • Non Hodgkin Lymphoma
  • Diffuse Large B Cell Lymphoma
  • Nanjing, Jiangsu, China
  • +1 more
Mar 9, 2022

DLBCL Germinal Center B-Cell Type Trial in China (Selinexor, Rituximab, Cyclophosphamide)

Recruiting
  • DLBCL Germinal Center B-Cell Type
  • Guangzhou, Guangdong, China
  • +5 more
Aug 16, 2022

Neuroblastoma Trial in Canada, United States (131I-MIBG, Vincristine, Irinotecan)

Completed
  • Neuroblastoma
  • 131I-MIBG
  • +3 more
  • Los Angeles, California
  • +13 more
Dec 21, 2021

Metastatic Medulloblastoma, High Risk Supratentorial PNET, Metastatic PNET Trial in Aurora (Carboplatin, Vincristine, 24 Gy)

Completed
  • Metastatic Medulloblastoma
  • +2 more
  • Aurora, Colorado
    Children's Hospital Colorado
Dec 13, 2021

Diffuse Large B Cell Lymphoma, CD79A Gene Mutation, CD79B Gene Mutation Trial in Zhengzhou (Rituximab, Zanubrutinib,

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +2 more
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Jan 22, 2022

Peripheral T-cell Lymphoma Targeted Therapy Trial in Tianjin (Azacitidine, Chidamide, Cyclophosphamide)

Enrolling by invitation
  • Peripheral T-cell Lymphoma Targeted Therapy
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Insititute & Hospital
Jan 9, 2023

Solid Tumor Trial in Cincinnati (Bevacizumab, Temozolomide, Vincristine)

Completed
  • Solid Tumor
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Feb 8, 2021

Mantle-Cell Lymphoma Trial in Miami (G-CSF, Rituximab, Cyclophosphamide)

Active, not recruiting
  • Mantle-Cell Lymphoma
  • G-CSF
  • +10 more
  • Miami, Florida
    University of Miami
Aug 12, 2021

Diffuse Large B Cell Lymphoma, DLBCL, Cancer Trial in Madison (Rituximab, Cyclophosphamide, Doxorubicin)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Nov 1, 2021

Leukemia Trial in Houston (Cyclophosphamide, Vincristine, Blinatumomab)

Not yet recruiting
  • Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Dec 23, 2022